Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling

BACKGROUND: Cabotegravir and rilpivirine are 2 long-acting (LA) antiretrovirals that can be administered intramuscularly; their interaction with rifampicin, a first-line antituberculosis agent, has not been investigated. The aim of this study was to simulate and predict drug–drug interactions (DDIs)...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Infect Dis
Glavni autori: Rajoli, Rajith K R, Curley, Paul, Chiong, Justin, Back, David, Flexner, Charles, Owen, Andrew, Siccardi, Marco
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Major Articles and Brief Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500558/
https://ncbi.nlm.nih.gov/pubmed/30566691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy726
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items